background image

Publications

  • Diabetic Retinopathy Clinical Research Network: Relationship Between Optical Coherence Tomography-Measured Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema. Ophthalmology 114:525, 2007.
  • Dexamethasone DDS Phase II Study Group: Randomized Controlled Study of an Intravitreous Dexamethasone Drug Delivery System in Patients with Persistent Macular Edema. Arch Ophthalmol 125:309, 2007.
  • Ahmed M, Niffenegger JH, Jakobiec FA, Ben-Arie-Weintrob Y, Gion N, Androudi S, Folberg R, Raizman MB, Margo CE, Smith ME, McLean IW, Caya JG, Foster CS.  Diagnosis of limited ophthalmic Wegener granulomatosis:  distinctive pathologic features with ANCA test confirmation. International Ophthalmology June 23, 2007 ePub
  • A Phase 2 Randomized, Muticenter, Dose-Ranging, Controlled, Parallel-Group Trial to Assess the Safety & Efficacy of Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) in the Treatment of Persistent Macular Edema. Protocol #OC103-06-03
  • Friberg TR, Musch DC, Lim JI, Morse L, Freeman W, Sinclair S, PTAMD Study Group: Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810—Nanometer Laser to Eyes with Drusen. Unilaterally Elilgible Patients. Ophthalmology 113:612, 2006.
  • Hudson HL, Land SS, Heir JS, Stulting RD, Singerman L, Lichter PR, Sternberg P, Chang DF, IMT-002 Study Grouop: Implantable Miniature Telescope for the Treatment of Visual Acuity Loss Resulting from End-Stage Age-Related Macular Degeneration: 1-year Results. Ophthalmology 113:1987, 2006.
  • Fong D, Niffenegger JH. Optimal Management of Diabetic Retinopathy. Chapt 9.
  • Efficient Eye Care. Fong D. ed.  Blackwell Science, 2000.
  • Barnett D, Aiello LM, Niffenegger JH, Fong D., Cavallerano JD.  Diabetes Mellitus.  Chapt. 324. Principles & Practices of Ophthalmology. Albert DM, Jakobiec FA, eds. Philadelphia: W.B. Saunders, 2000, Vol 5, pp. 4525-4541.
  • Zegarra H, Finkelstein D, Singerman LJ, Niffenegger JH. Laser management of branch and central vein occlusions. In Singerman LJ, Coscas G (eds). Current Techniques in Ophthalmology Surgery.  Philadelphia: Current Medicine, 1999, pp 67-76.
  • Niffenegger JH, Pendergast SD, Singerman LJ. Laser management of less common macular diseases. In Singerman LJ, Coscas G (eds). Current Techniques in Ophthalmic Laser Surgery. Philadelphia:  Current Medicine, 1999, pp 111-128.
  • Niffenegger JH, Pendergast SD, Singerman LJ. Photocoagulation of other causes of choroidal neovascularization. In Singerman LJ, Coscas G (eds). Current Techniques in Ophthalmic Laser Surgery.  Philadelphia: Current Medicine, 1999, pp 91-110.
  • Pendergast SD, Singerman, LJ. Zegarra H, Niffenegger JH. Laser in the treatment of proliferative retinopathies. Current Technique in Ophthalmic Laser Surgery. Philadelphia, Current Medicine , 1999. pp. 35-53.
  • Singerman LJ, Pendergast SD, Niffenegger JH, Zegarra H. Laser treatment for proliferative diabetic retinopathy. Proceedings of the New Orleans Academy of Ophthalmology Symposium.  The Hague: Kugler Publications, 1998, pp 97-121.
  • Niffenegger JH, Singerman LJ. Other causes of choroidal neovascularization. In Guyer DR. Yannuzzi LA, Chang S, Shields J, Green WR (eds).  Retina, Vitreous, Macula: A Comprehensive Text, Chapter 14. Philadelphia: Saunders, 1998.
  • Niffenegger JH, Topping TM, Mukai S.  Stickler’s Syndrome. International Ophthalmology Clinics 33:271-280, 1993.
  • Niffenegger JH, Jakobiec FA, Shore JW, Albert DM.  Adult extrarenal rhabdoid tumor of the lacrimal gland. Ophthalmology 99:567-74, 1992.
  • Seiving PA, Niffenegger JH, Berson EL.  Electrophysiologic findings in selected pedigrees with choroideremia. American Journal of Ophthalmology 101:361-367, 1986.
  • Benson DW, Weinstein ES, Niffenegger JH, Yokum M, Fry DE.  Subpopulations of skeletal muscle mitochondria: response to ischemia. American Surgeon  51:682-686, 1985. Second Place winner, Forum of Progress in Surgery, 53rd. Assembly of the Southeastern Surgical Conference, 1985.